Literature DB >> 12464198

Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia.

V M S de Bruin1, M C M Vieira, M N M Rocha, G S B Viana.   

Abstract

We have studied the relationship between dehydroepiandrosterone sulfate (DHEAS), cortisol, and cognitive function in a population of demented patients (n=29), age-matched controls (n=46), and younger subjects (n=11). All were submitted to morning collection of blood for determination of plasma cortisol and DHEAS measured by 125I radioimmunoassay. DHEAS levels and cortisol/DHEAS ratios were significantly different among groups with higher DHEAS levels and lower cortisol/DHEAS ratios in younger people (Bonferroni p<.05). Cortisol levels were associated to the presence of dementia (Odds ratio=.93; 95% CI,.86-1.01). There was no difference between DHEAS levels of demented and age-matched controls; however, demented patients showed a trend for higher cortisol/DHEAS ratios than age-matched controls and the latter showed higher ratio values than younger subjects. DHEAS and cortisol plasma values were significantly correlated in all individuals (p<.01). In this study cortisol was independently associated to the presence of dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464198     DOI: 10.1016/s0278-2626(02)00519-5

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  14 in total

1.  Measuring DHEA-S in saliva: time of day differences and positive correlations between two different types of collection methods.

Authors:  Courtney A Whetzel; Laura C Klein
Journal:  BMC Res Notes       Date:  2010-07-20

2.  Chronic Stress Decreases Basal Levels of Memory-Related Signaling Molecules in Area CA1 of At-Risk (Subclinical) Model of Alzheimer's Disease.

Authors:  Karim A Alkadhi; Trinh T Tran
Journal:  Mol Neurobiol       Date:  2014-08-12       Impact factor: 5.590

Review 3.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

4.  Combinations of biomarkers predictive of later life mortality.

Authors:  Tara L Gruenewald; Teresa E Seeman; Carol D Ryff; Arun S Karlamangla; Burton H Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Hormonal determinants and effect of ER22/23EK glucocorticoid receptor gene polymorphism on health status deterioration in the participants of the Mataró Ageing Study.

Authors:  Mireia Mora; Lidia Sánchez; Mateu Serra-Prat; Elisabet Palomera; Jesús Blanco; Gloria Aranda; Immaculada Falcón; Immaculada Cadenas; Xavier Boquet; Josep Oriola; Manuel Puig-Domingo
Journal:  Age (Dordr)       Date:  2011-05-05

6.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

Review 7.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

8.  Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke.

Authors:  Claudine A Blum; Cornelia Mueller; Philipp Schuetz; Felix Fluri; Michael Trummler; Beat Mueller; Mira Katan; Mirjam Christ-Crain
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Chronic stress and Alzheimer's disease-like pathogenesis in a rat model: prevention by nicotine.

Authors:  Karim A Alkadhi
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

10.  Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?

Authors:  Alfredo Robles
Journal:  Open Neurol J       Date:  2009-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.